301393 logo

Suzhou Highfine Biotech XSEC:301393 Stock Report

Last Price

CN¥52.02

Market Cap

CN¥5.6b

7D

10.4%

1Y

13.1%

Updated

22 May, 2025

Data

Company Financials

Suzhou Highfine Biotech Co., Ltd.

XSEC:301393 Stock Report

Market Cap: CN¥5.6b

301393 Stock Overview

Manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China. More details

301393 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Rewards

Earnings grew by 50.3% over the past year

Risk Analysis

High level of non-cash earnings

Volatile share price over the past 3 months compared to the CN market

Dividend of 0.75% is not well covered by free cash flows


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Suzhou Highfine Biotech Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Suzhou Highfine Biotech
Historical stock prices
Current Share PriceCN¥52.02
52 Week HighCN¥55.20
52 Week LowCN¥33.26
Beta0
1 Month Change12.09%
3 Month Change22.00%
1 Year Change13.09%
3 Year Changen/a
5 Year Changen/a
Change since IPO-41.15%

Recent News & Updates

Recent updates

Shareholder Returns

301393CN PharmaceuticalsCN Market
7D10.4%4.3%-0.4%
1Y13.1%5.1%8.4%

Return vs Industry: 301393 exceeded the CN Pharmaceuticals industry which returned 5.1% over the past year.

Return vs Market: 301393 exceeded the CN Market which returned 8.4% over the past year.

Price Volatility

Is 301393's price volatile compared to industry and market?
301393 volatility
301393 Average Weekly Movement8.5%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.9%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 301393's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 301393's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
2003428Yong Zhuwww.highfine.com

Suzhou Highfine Biotech Co., Ltd. manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China. The company’s products include characteristic amide bonds, building blocks, protein reagents, protein crosslinkers, peptide reagents, protective amino acids, ionic liquids, PROTAC reagents, unnatural amino acids, pharmaceutical reagents of liposomes and lipid nanoparticles, nucleotide reagents, etc. Its products are used in fields of peptide, nucleotide, and pharmaceutical synthesis. The company also exports its products.

Suzhou Highfine Biotech Co., Ltd. Fundamentals Summary

How do Suzhou Highfine Biotech's earnings and revenue compare to its market cap?
301393 fundamental statistics
Market capCN¥5.56b
Earnings (TTM)CN¥139.02m
Revenue (TTM)CN¥495.86m
40.0x
P/E Ratio
11.2x
P/S Ratio

Is 301393 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301393 income statement (TTM)
RevenueCN¥495.86m
Cost of RevenueCN¥298.69m
Gross ProfitCN¥197.17m
Other ExpensesCN¥58.14m
EarningsCN¥139.02m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.30
Gross Margin39.76%
Net Profit Margin28.04%
Debt/Equity Ratio0%

How did 301393 perform over the long term?

See historical performance and comparison

Dividends

0.7%
Current Dividend Yield
30%
Payout Ratio

Does 301393 pay a reliable dividends?

See 301393 dividend history and benchmarks
When do you need to buy 301393 by to receive an upcoming dividend?
Suzhou Highfine Biotech dividend dates
Ex Dividend DateMay 22 2025
Dividend Pay DateMay 22 2025
Days until Ex dividend1 day
Days until Dividend pay date1 day

Does 301393 pay a reliable dividends?

See 301393 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 17:59
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Suzhou Highfine Biotech Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Song YangTianfeng Securities Brokerage Co., Ltd